Cite
HARVARD Citation
Gonzalez-Exposito, R. et al. (2019). CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. Journal for immunotherapy of cancer. 7 (1), p. . [Online].